Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

• Published in: Vaccine 2003-06, Vol.21 (21), p.2954-2963
• Main Authors: Yasuda, Yoko, Isaka, Masanori, Taniguchi, Tooru, Zhao, Yanqiu, Matano, Keiko, Matsui, Hideyuki, Morokuma, Kazunori, Maeyama, Jun-ichi, Ohkuma, Kunio, Goto, Norihisa, Tochikubo, Kunio
• Format: Article
• Language: English
• Subjects: Administration, Intranasal; Animals; Anti-rCTB immunity; Antibodies, Bacterial - blood; Antitoxins; Applied microbiology; Bacterial diseases; Biological and medical sciences; Cholera; Cholera Toxin - administration & dosage; Cholera Toxin - immunology; Chromatography; Diphtheria; Diphtheria toxoid; Diphtheria Toxoid - administration & dosage; Diphtheria Toxoid - immunology; Dose-Response Relationship, Immunologic; Ent and stomatologic bacterial diseases; Female; Frequent nasal immunizations; Fundamental and applied biological sciences. Psychology; Human bacterial diseases; Immune system; Immunity, Mucosal; Immunization; Immunization Schedule; Immunoglobulin G - blood; Infectious diseases; Laboratory animals; Medical sciences; Mice; Mice, Inbred BALB C; Microbiology; Proteins; Recombinant cholera toxin B subunit (rCTB) adjuvant; Rodents; Tetanus; Tetanus toxoid; Tetanus Toxoid - administration & dosage; Tetanus Toxoid - immunology; Time Factors; Toxins; Tropical bacterial diseases; Vaccines; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Vaccines, Synthetic - administration & dosage; Vaccines, Synthetic - immunology; Waterborne diseases
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/S0264-410X(03)00114-2

Vaccination via a mucosal route is a very attractive means for immunization, because both local and systemic immune responses are inducible and vaccines can be administered easily and safely from infants to elderly persons. For developing widely applicable mucosal vaccines using recombinant cholera toxin B subunit (rCTB) as a safe adjuvant, we examined whether frequent nasal administrations of rCTB-containing same and different vaccines could induce antigen-specific immune responses without induction of systemic tolerance and suppression by pre-existing anti-rCTB immunity. Ten repetitive nasal administrations to mice of tetanus toxoid (TT) + rCTB or diphtheria toxoid (DT) + rCTB raised and maintained high levels of antigen- and rCTB-specific serum IgG including high levels of tetanus/diphtheria antitoxin titres and raised nasal, salivary, lung, vaginal and fecal secreted IgA, suggesting that the regimen did not induce systemic tolerance to TT/DT and rCTB. Mice successively received repetitive five doses of TT as the first antigen and subsequent five doses of DT as the second antigen, and vice versa, raised serum IgG to the second antigen at various levels including low but sufficient protective levels of antitoxin titres and induced mucosal IgA in the lungs, the vaginas and feces, but hardly in the nasal secretions and salivas. After an interval of 22 weeks between the dosage of the first and second antigens, mice induced serum IgG to the second antigen at high levels and mucosal IgA in all sites. In conclusion, anti-TT and -DT serum and mucosal antibody responses induced by repeated intranasal immunization using rCTB adjuvant lasted for a long period, and for improving the effectivity of vaccination, different rCTB-containing vaccines should be administered at appropriate intervals.